Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 7 min ago
PreprintarXiv licencearXiv

Radiomics-Based Thyroid Nodule Classification with Label-Conditional Conformal Prediction

Abstract

Thyroid nodule malignancy assessment relies on ultrasound imaging, yet current risk stratification systems suffer from substantial interobserver variability, contributing to a high rate of unnecessary biopsies. We propose a radiomics-based framework combining quantitative feature extraction via PyRadiomics with a Generalized Additive Model (GAM) classifier, selected among six candidates for its favorable trade-off between discriminative performance and interpretability. To complement point predictions with uncertainty estimates, Cross-Conformal Prediction with label-conditional guarantees is applied, flagging ambiguous cases for clinical review rather than forcing a binary decision. Experiments are conducted on TN5000, a publicly available ultrasound dataset of thyroid nodules. After Spearman correlation filtering, 36 features are retained and the GAM achieves an AUC of $0.89$, a sensitivity of $0.83$, and a specificity of $0.82$ on the validation set. At a significance level ε=0.09, selected to ensure empirical coverage guarantees on both classes, 63\% of nodules on the test set receive a certain (i.e., single-label) prediction, with conditional precision of $0.94$ for certain malignant and conditional Negative Predictive Value (NPV) of $0.73$ for certain benign cases, while the remaining 37\% are referred to the clinician.

Related

  1. Conformal Prediction and Conditional Coverage for Tabular Foundation Models
    Sungwoo Park, Sunghee Park, Won Chang
    arXivPreprintCC BY 4.0Full textStatisticsarXiv
  2. Metric Conformal Prediction via the Conditional Expected Local Radius
    Rui Qiu, Fang Yao, Zhou Yu
    arXivPreprintarXiv licenceFull textStatisticsarXiv
  3. How Synthetic Labels Improve Conformal Prediction: A Perspective on Conditional Coverage
    Qianyi Chen, Bo Li
    arXivPreprintarXiv licenceFull textStatisticsarXiv
  4. Sharp training-conditional coverage for conformal prediction under covariate shift
    Mehrdad Pournaderi
    arXivPreprintarXiv licenceFull textStatisticsarXiv
  5. Uncertainty aware prediction from incomplete clinical records: a conformal prediction study of Parkinsonian classification using C-OPN data
    Jiaqi Bi, Jialu Sun, Hanrui Dou +4
    arXivPreprintarXiv licenceFull textStatisticsarXiv
BibTeX
@misc{testa2026radiomicsbased,
  title = {{Radiomics-Based Thyroid Nodule Classification with Label-Conditional Conformal Prediction}},
  author = {Laura Testa and Pierpaolo Brutti and Umberto Ferraro Petrillo},
  howpublished = {arXiv},
  year = {2026},
  month = oct,
  doi = {10.48550/arxiv.2610.13387},
  eprint = {2610.13387},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2610.13387},
}
RIS
TY  - UNPB
TI  - Radiomics-Based Thyroid Nodule Classification with Label-Conditional Conformal Prediction
AU  - Laura Testa
AU  - Pierpaolo Brutti
AU  - Umberto Ferraro Petrillo
PY  - 2026
DA  - 2026/10/09
PB  - arXiv
DO  - 10.48550/arxiv.2610.13387
UR  - https://arxiv.org/abs/2610.13387
AB  - Thyroid nodule malignancy assessment relies on ultrasound imaging, yet current risk stratification systems suffer from substantial interobserver variability, contributing to a high rate of unnecessary biopsies. We propose a radiomics-based framework combining quantitative feature extraction via PyRadiomics with a Generalized Additive Model (GAM) classifier, selected among six candidates for its favorable trade-off between discriminative performance and interpretability. To complement point predictions with uncertainty estimates, Cross-Conformal Prediction with label-conditional guarantees is applied, flagging ambiguous cases for clinical review rather than forcing a binary decision. Experiments are conducted on TN5000, a publicly available ultrasound dataset of thyroid nodules. After Spearman correlation filtering, 36 features are retained and the GAM achieves an AUC of $0.89$, a sensitivity of $0.83$, and a specificity of $0.82$ on the validation set. At a significance level ε=0.09, selected to ensure empirical coverage guarantees on both classes, 63\% of nodules on the test set receive a certain (i.e., single-label) prediction, with conditional precision of $0.94$ for certain malignant and conditional Negative Predictive Value (NPV) of $0.73$ for certain benign cases, while the remaining 37\% are referred to the clinician.
ER  -